The Latest Breaking News from Cancer

Ifosfamide Is Scarce at 94 Percent of Surveyed Cancer Centers, and Every Responding Center Reports a Drug Shortage

Every cancer center in a new NCCN survey reports at least one drug shortage, led by ifosfamide. What patients in treatment should ask now.

Medical Daily · Sep 11

Kate makes surprise visit to London's Royal Marsden Hospital to thank staff for cancer treatment

Princess of Wales praised the ‘incredible’ cancer care she received at the Royal Marsden in a surprise visit on Friday

Evening Standard · Sep 11

Kate returns to cancer hospital to say thank you for care she received

The Princess of Wales said plans to expand patients’ holistic care through a new centre at the Royal Marsden would be ‘transformative’.

The Independent UK · Sep 11

Mike McFarland death: Beloved voice of Master Roshi in Dragon Ball Z and Buggy in One Piece dies aged 56

Voice actor dies from aggressive form of brain cancer known as glioblastoma

The Independent UK · Sep 11

9/11 25th Anniversary Adds Seventh Moment of Silence for Nearly 10,000 Killed by Toxic Exposure

The 25th 9/11 anniversary adds a seventh moment of silence as nearly 10,000 deaths from Ground Zero's toxic dust now outnumber the 2,977 killed in the 2001 attacks.

International Business Times UK · Sep 11

A 2024 review investigated the ‘immortal jellyfish’ and found that it can reverse its life cycle through cellular reprogramming, revealing clues to biological rejuvenation that may also carry cancer risks in humans

The immortal jellyfish, known scientifically as Turritopsis dohrnii, possesses an extraordinary ability to reverse its life cycle when under stress. This fascinating process encompasses cellular transdifferentiation and alterations in gene activity. Researchers are delving into its DNA repair and telomere maintenance strategies. Although humans can also reprogram cells, such procedures…

The Economic Times · Sep 11

Lung Cancer Patients With HER2 Mutations Can Now Start a Daily Targeted Pill Before Any Other Systemic Treatment

The FDA expanded sevabertinib, sold as Hyrnuo, to first-line use for HER2-mutant lung cancer. Who qualifies, trial results, and key side effects.

Medical Daily · Sep 11

Esther Rantzen Says Assisted-Dying Ban Is 'Messy and Cruel' After Her 'Last Chance' Is Gone

Dame Esther Rantzen says terminal lung cancer has left her too physically fragile to travel to Dignitas, as MPs prepare to debate assisted dying legislation in England and Wales.

International Business Times UK · Sep 10

Esther Rantzen now ‘too physically fragile’ to end her life in Switzerland

Broadcaster, 86, had intended to end her life in Swiss clinic after being diagnosed with terminal lung cancer in 2023

The Guardian - UK · Sep 10

Teen Uses Cancer Game: Daniel Zhang turns Tumor Tactics into learning tool; reaches 1,500 K-8 students

In an innovative step, a San Diego teenager named Daniel Zhang crafted Tumor Tactics, an educational game designed to demystify cancer for young minds. Motivated by his grandmother's battle with the illness, Daniel aims to make intricate cancer biology accessible to children. His project has garnered funding and will be…

The Times of India · Sep 10